357 related articles for article (PubMed ID: 18406345)
21. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J
Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546
[TBL] [Abstract][Full Text] [Related]
22. Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.
Ikeda M; Abe K; Dansako H; Nakamura T; Naka K; Kato N
Biochem Biophys Res Commun; 2005 Apr; 329(4):1350-9. PubMed ID: 15766575
[TBL] [Abstract][Full Text] [Related]
23. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication.
Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R
Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180
[TBL] [Abstract][Full Text] [Related]
24. Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system.
Bourne N; Pyles RB; Yi M; Veselenak RL; Davis MM; Lemon SM
Antiviral Res; 2005 Aug; 67(2):76-82. PubMed ID: 15927278
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial electron transport inhibition in full genomic hepatitis C virus replicon cells is restored by reducing viral replication.
Ando M; Korenaga M; Hino K; Ikeda M; Kato N; Nishina S; Hidaka I; Sakaida I
Liver Int; 2008 Sep; 28(8):1158-66. PubMed ID: 18410284
[TBL] [Abstract][Full Text] [Related]
26. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
27. Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagents.
Nishimura G; Ikeda M; Mori K; Nakazawa T; Ariumi Y; Dansako H; Kato N
Antiviral Res; 2009 Apr; 82(1):42-50. PubMed ID: 19428594
[TBL] [Abstract][Full Text] [Related]
28. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
[TBL] [Abstract][Full Text] [Related]
30. The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA.
Chang KS; Luo G
Virus Res; 2006 Jan; 115(1):1-8. PubMed ID: 16102869
[TBL] [Abstract][Full Text] [Related]
31. Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well.
Mondal R; Koev G; Pilot-Matias T; He Y; Ng T; Kati W; Molla A
Antiviral Res; 2009 Apr; 82(1):82-8. PubMed ID: 19174175
[TBL] [Abstract][Full Text] [Related]
32. Suppression of hepatitis C virus replicon by TGF-beta.
Murata T; Ohshima T; Yamaji M; Hosaka M; Miyanari Y; Hijikata M; Shimotohno K
Virology; 2005 Jan; 331(2):407-17. PubMed ID: 15629783
[TBL] [Abstract][Full Text] [Related]
33. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.
Kato N; Mori K; Abe K; Dansako H; Kuroki M; Ariumi Y; Wakita T; Ikeda M
Virus Res; 2009 Dec; 146(1-2):41-50. PubMed ID: 19720094
[TBL] [Abstract][Full Text] [Related]
34. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
[TBL] [Abstract][Full Text] [Related]
35. Replication of hepatitis C virus genotype 3a in cultured cells.
Saeed M; Gondeau C; Hmwe S; Yokokawa H; Date T; Suzuki T; Kato T; Maurel P; Wakita T
Gastroenterology; 2013 Jan; 144(1):56-58.e7. PubMed ID: 22999961
[TBL] [Abstract][Full Text] [Related]
36. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
Gottwein JM; Bukh J
Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
[TBL] [Abstract][Full Text] [Related]
37. Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy.
Watashi K; Shimotohno K
Rev Med Virol; 2007; 17(4):245-52. PubMed ID: 17299803
[TBL] [Abstract][Full Text] [Related]
38. Replication of a novel subgenomic HCV genotype 1a replicon expressing a puromycin resistance gene in Huh-7 cells.
Liang C; Rieder E; Hahm B; Jang SK; Paul A; Wimmer E
Virology; 2005 Mar; 333(1):41-53. PubMed ID: 15708591
[TBL] [Abstract][Full Text] [Related]
39. Targeting lipid metabolism in the treatment of hepatitis C virus infection.
Amemiya F; Maekawa S; Itakura Y; Kanayama A; Matsui A; Takano S; Yamaguchi T; Itakura J; Kitamura T; Inoue T; Sakamoto M; Yamauchi K; Okada S; Yamashita A; Sakamoto N; Itoh M; Enomoto N
J Infect Dis; 2008 Feb; 197(3):361-70. PubMed ID: 18248300
[TBL] [Abstract][Full Text] [Related]
40. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells.
Choi J; Lee KJ; Zheng Y; Yamaga AK; Lai MM; Ou JH
Hepatology; 2004 Jan; 39(1):81-9. PubMed ID: 14752826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
